At the end of 2023, more than one-third of new prescriptions to treat Type 2 diabetes were GLP-1s, such as Mounjaro and Ozempic, among others, according to a study published April 15 in Annals of ...

A recent systematic review and meta-analysis published in BMC Health Services Research (Awopeju et al., 2022) shed light on healthcare-seeking behavior among young adults in sub-Saharan Africa. The ...